Better process development is creating industry benchmarks for bioprocessing.

Contract manufacturers are essential players that allow biopharmaceutical companies the flexibility to address fluctuating product demand and the ability to outsource projects that are not strategically critical..

Althea is expanding its existing biological drug product manufacturing operations to include highly active materials, such as antibody-drug conjugates, in a new facility near San Diego, CA.

Despite emergence of biologics, small-molecule APIs benefit from industry growth.

Pharma development and manufacturing firm Patheon announces new tagline and logo.

FDA announced the recall, citing deficiencies in Medistat’s aseptic processing areas and in its environmental monitoring procedures.

Suppliers indicate prices for single-use equipment are likely to increase.

Under the terms of the agreement, EMCM will make Reniale, a biologic vaccine meant to prevent the development of new metastases.

When should CMOs and their pharma clients share the details of their partnerships with outside parties?

Focusing on niche and specialty service offerings gives contract biomanufacturing organizations an opportunity to differentiate in a crowded market.